Cubist Systematic Strategies, LLC Novartis Ag Transaction History

Cubist Systematic Strategies, LLC

  • $15.1 Billion
  • Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 56,891 shares of NVS stock, worth $6.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
56,891
Holding current value
$6.2 Million
% of portfolio
0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$96.78 - $117.18 $5.51 Million - $6.67 Million
56,891 New
56,891 $5.54 Million
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $8.3 Million - $9.45 Million
87,081 Added 157.8%
142,265 $13.8 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $2.2 Million - $2.42 Million
23,827 Added 75.99%
55,184 $5.57 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $5.79 Million - $6.42 Million
-61,100 Reduced 66.08%
31,357 $3.19 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $8.42 Million - $9.55 Million
91,057 Added 6504.07%
92,457 $9.33 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $497,146 - $576,535
-6,212 Reduced 81.61%
1,400 $128,000
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $3.5 Million - $4.28 Million
-46,284 Reduced 85.88%
7,612 $690,000
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $711,630 - $832,285
-9,538 Reduced 15.04%
53,896 $4.1 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $711,630 - $832,285
-9,538 Reduced 15.04%
53,896 $4.1 Million
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $2.1 Million - $2.45 Million
26,138 Added 70.08%
63,434 $5.36 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $8.21 Million - $9.29 Million
-102,529 Reduced 73.33%
37,296 $3.27 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $10.4 Million - $11.5 Million
129,992 Added 1322.0%
139,825 $12.2 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $1.9 Million - $2.21 Million
-23,207 Reduced 70.24%
9,833 $804,000
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $913,858 - $1.01 Million
10,721 Added 48.04%
33,040 $3.02 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $1.69 Million - $1.99 Million
20,182 Added 944.41%
22,319 $1.91 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $146,849 - $177,622
-1,881 Reduced 46.81%
2,137 $202,000
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $25,791 - $28,574
314 Added 8.48%
4,018 $349,000
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $1.01 Million - $1.13 Million
-12,456 Reduced 77.08%
3,704 $324,000
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $650,800 - $911,783
-9,209 Reduced 36.3%
16,160 $1.33 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $1.73 Million - $1.95 Million
20,465 Added 417.31%
25,369 $2.4 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $221,120 - $243,662
-2,585 Reduced 34.52%
4,904 $426,000
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $51,649 - $63,568
685 Added 10.07%
7,489 $684,000
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $438,588 - $501,651
-5,823 Reduced 46.12%
6,804 $654,000
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $227,167 - $252,949
-3,084 Reduced 19.63%
12,627 $1.08 Million
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $329,813 - $381,497
-4,927 Reduced 23.87%
15,711 $1.35 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $931,069 - $1.05 Million
14,344 Added 227.9%
20,638 $1.56 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $13,092 - $15,651
-186 Reduced 2.87%
6,294 $509,000
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $225,090 - $241,615
3,112 Added 92.4%
6,480 $544,000
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $249,703 - $260,245
3,368
3,368 $289,000

Others Institutions Holding NVS

# of Institutions
1,476
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $234B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email